ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests

Masoodi, Mojgan*; Gastaldelli, Amalia; Hyotylainen, Tuulia; Arretxe, Enara; Alonso, Cristina; Gaggini, Melania; Brosnan, Julia; Anstee, Quentin M.; Millet, Oscar; Ortiz, Pablo; Mato, Jose M.; Dufour, Jean-Francois; Oresic, Matej*
Nature Reviews. Gastroenterology and Hepatology2021-12DOI: 10.1038/s41575-021-00502-9
236被引6阅读
引用收藏
分享

摘要

Metabolomics and lipidomics approaches are being used to identify biomarkers for nonalcoholic fatty liver disease (NAFLD). This Review discusses the application of metabolomics and lipidomics in clinical studies and in the identification of key metabolic pathway alterations in NAFLD. Nonalcoholic fatty liver disease (NAFLD) is one of the most common liver diseases worldwide and is often associated with aspects of metabolic syndrome. Despite its prevalence and the importance of early diagnosis, there is a lack of robustly validated biomarkers for diagnosis, prognosis and monitoring of disease progression in response to a given treatment. In this Review, we provide an overview of the contribution of metabolomics and lipidomics in clinical studies to identify biomarkers associated with NAFLD and nonalcoholic steatohepatitis (NASH). In addition, we highlight the key metabolic pathways in NAFLD and NASH that have been identified by metabolomics and lipidomics approaches and could potentially be used as biomarkers for non-invasive diagnostic tests. Overall, the studies demonstrated alterations in amino acid metabolism and several aspects of lipid metabolism including circulating fatty acids, triglycerides, phospholipids and bile acids. Although we report several studies that identified potential biomarkers, few have been validated.

学科与关键词

关键词
FATTY-LIVER-DISEASETISSUE INSULIN-RESISTANCECHAIN AMINO-ACIDSCIRCULATING TRIACYLGLYCEROL SIGNATURESDE-NOVO LIPOGENESISNONALCOHOLIC STEATOHEPATITISBRANCHED-CHAINADIPOSE-TISSUENONDIABETIC PATIENTSSYSTEMS BIOLOGY
相关
加载中…
  • Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity
    Pirola, Carlos J.; Sookoian, Silvia*WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24(15): 1601-1615.被引 51
  • Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy
    Beyoglu, Diren; Idle, Jeffrey R.*Metabolites, 2020, 10(2): 50.被引 56
  • Network Modeling Approaches and Applications to Unravelling Non-Alcoholic Fatty Liver Disease
    Blencowe, Montgomery; Karunanayake, Tilan; Wier, Julian; Hsu, Neil; Yang, Xia*Genes, 2019, 10(12): 966.被引 25
查看全部 →

发表信息

论文状态
公开发表
期刊
Nature Reviews. Gastroenterology and Hepatology
发表日期
2021-12
卷期
第 18 卷, 第 12 期
页码
835-856
DOI
10.1038/s41575-021-00502-9
语言
ENGLISH
期刊等级
1区
成果收录
SCIE
资助标注
EU's Horizon 2020 Programme under the EPoS project [634413]; Innovative Medicines Initiative 2 Joint Undertaking under the LITMUS project [777377]; Swiss National Science Foundation (SNSF) [190686]; EFPIA; EU's Horizon 2020 programme; H2020 Societal Challenges Programme [634413] Funding Source: H2020 Societal Challenges Programme

作者

  • M

    Masoodi, Mojgan (通讯) (第一作者)

  • G

    Gastaldelli, Amalia

查看全部 13 位作者收起作者
  • H

    Hyotylainen, Tuulia

  • A

    Arretxe, Enara

  • A

    Alonso, Cristina

  • G

    Gaggini, Melania

  • B

    Brosnan, Julia

  • A

    Anstee, Quentin M.

  • M

    Millet, Oscar

  • O

    Ortiz, Pablo

  • M

    Mato, Jose M.

  • D

    Dufour, Jean-Francois

  • O

    Oresic, Matej (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417